Citations 1
Peri-Transplant and Maintenance Daratumumab for Minimal Residual Disease (MRD) Eradication in Transplant-Eligible Multiple Myeloma (MM) Patients
Pérez, Gabriela , Kharfan‐Dabaja, Mohamed A. , Ayala, Ernesto, O’Brien, Patrick, Alegria, Victoria R., Zimmerman, Ashley, Chapin, Dustin, Lanier, Stephanie, Kasik, Carly, Bradley, Schannon, Sher, Taimur , Paulus, Aneel , Chanan‐Khan, Asher , Paulus, Aneel , Ailawadhi, Sikander , Parrondo, Ricardo D , Murthy, Hemant S. , Roy, Vivek
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10165-10166
